The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cost-effectiveness of adjuvant chemotherapy for stage III colon cancer in the South African public healthcare setting.
 
Yoanna S Pumpalova
No Relationships to Disclose
 
Alexandra M. Rogers
Employment - United Health Group (I)
 
Sarah Xinhui Tan
No Relationships to Disclose
 
Candice-Lee Herbst
Employment - Amgen; Mylan; Sanofi
 
Paul Ruff
Speakers' Bureau - Amgen (Inst); Mylan (Inst)
Research Funding - AstraZeneca (Inst); Janssen Oncology (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Dr. Reddy's Laboratories; Merck Serono; MSD Oncology; Pfizer; Roche
 
Alfred I. Neugut
Stock and Other Ownership Interests - Stemline Therapeutics
Consulting or Advisory Role - EHE International; Eisai; GlaxoSmithKline; Otsuka; United Biosource Corporation
Research Funding - Otsuka (Inst)
Expert Testimony - Hospira
 
Chin Hur
Stock and Other Ownership Interests - Cambridge Biomedical and Economic Consulting Group
Honoraria - Gilead Sciences; Novo Nordisk